| (210) | Number of the EPO application | 18716455 |
| (220) | Filing date of the EPO application | 2018.03.20 |
| (80) | EPO patent specification publication (B) | EPB nr. 28/2019, 2019.07.10 |
| (110) | EPO patent number | 3448859 |
| (11) | Number of the document | MD 3448859 T2 |
| (21) | Number of the application | e 2019 0287 |
| (71) | Name(s) of applicant(s), code of the country | Forma Therapeutics, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | ERICSSON Anna, US;
GREEN Neal, US;
GUSTAFSON Gary, US;
HAN Bingsong, US;
LANCIA JR. David R., US;
MITCHELL Lorna, US;
RICHARD David, US;
SHELEKHIN Tatiana, US;
SMITH Chase C., US;
WANG Zhongguo, US;
ZHENG Xiaozhang, US; |
| (73) | Name(s) of owner(s), code of the country | Novo Nordisk Health Care AG, CH; |
| (54) | Title of the invention | Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 487/04 (2006.01.01); A61K 31/407 (2006.01.01); C07D 519/00 (2006.01.01); A61P 7/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.09.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2020.03.31 |
| (30) | Priority | 201762473751 P, 2017.03.20, US |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| | Assignment contract | | Nr. şi data deciziei: | 4245, 07.02.2024 | | Nr. şi data contractului: | 3886, 07.02.2024 | | Cedent(i): | FORMA Therapeutics Inc.
500 Arsenal St., Suite 100 Watertown, MA 02472, Statele Unite Ale Americii | | Cesionar(i): | Novo Nordisk Health Care AG
The Circle 32/38, 8058 Zürich, Elveţia |
|
| (86) | International application | PCT/US2018/023405, 2018.03.20 |
| (87) | International publication | WO 2018/175474, 2018.09.27 |